Stephens initiated coverage on Thermo Fisher Scientific, recognizing its industry leadership in life sciences with a projected $42.9 billion sales in 2023. The company's strategic mergers and acquisitions have bolstered its presence in the biopharma sector, offering growth potential and margin expansion opportunities.